Qiagen N.V. (QGEN) Market Cap & Valuation Ratios
Qiagen N.V. (QGEN) has a market cap of $10.9B and a price-to-sales ratio of 5.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
QGENQiagen N.V.Follow QGEN — free
—
Price chart with a free account
- Market cap
- 10.9B
- Annual P/E
- —
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 2 Feb, in 101 days
Peers
diagnostics & research · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| QGEN | 11 | 26.0 | 5.5 | 17.4 | 4.1% | +3% | 22% | 9% |
| GH | 23 | — | 19.6 | — | -1.1% | +43% | -40% | -231% |
| MEDP | 19 | 37.2 | 6.3 | 28.4 | 3.6% | +20% | 21% | — |
| RVTY | 18 | 76.0 | 6.8 | 25.8 | 3.2% | +4% | 12% | 3% |
| CRL | 16 | — | 4.7 | 48.7 | 2.2% | -0.7% | 2% | 1% |
| ICLR | 14 | — | 2.0 | 25.1 | 6.2% | +2% | 4% | 2% |
| TWST | 8.8 | — | 20.0 | — | -1.1% | +19% | -34% | -42% |
| GRAL | 5.9 | — | 35.5 | — | -5.0% | +23% | -338% | -24% |
| RDNT | 5.5 | — | 2.7 | 25.4 | 1.3% | +19% | 3% | 3% |
| SHC | 5.2 | 31.8 | 5.7 | 13.0 | 2.2% | +8% | 34% | 10% |
| BLLN | 5.1 | 193.9 | 11.6 | 92.1 | 0.7% | +90% | 11% | 54% |
| Median of these 10 | 56.6 | 6.6 | 25.8 | 1.7% | +19% | 3% | 2% |
P/E 26.0 vs. a peer median of 56.6; EV/Sales 5.5 vs. 6.6. QGEN's own P/E sits at the 47th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesGH and CRL and ICLR and TWST and GRAL and RDNT have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Qiagen N.V. — questions
- What is Qiagen N.V.'s market cap?
- $10.9B.
- What is Qiagen N.V.'s price-to-sales ratio?
- 5.2.
Every figure on this page comes from Qiagen N.V.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.